- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02490215
Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 ) will be screened at ICU admission and daily for the occurrence of ARDS ( AECC criteria) for a maximum of 28 days after ICU admission.
Data collection:
- For all patients, Demographic characteristics, admission category, the patient source intervention during ICU , APACHEII , SOFA score and discharge information will be collected
- For patients with ARDS, data about ABG , parameters of MV, hemodynamic on day0 to day7 and last day of MV will be collected.
- For patients without ARDS at ICU admission, data about risk factor for ARDS ,such as LIPS score, parameters of MV , and fluid balance on ICU day0 to day7 will be collected.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Beijing
-
Beijing, Beijing, China
- Peking University People's Hospital
-
Beijing, Beijing, China, 100730
- MICU, Peking union medical college hospital
-
Beijing, Beijing, China
- Beijing Hospital of Ministry of Health
-
Beijing, Beijing, China
- Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University
-
Beijing, Beijing, China
- General ICU, Beijing Tongren Hospital, Capital Medical University
-
Beijng, Beijing, China
- China-Japan Friendship Hospital
-
-
Chongqing
-
ChongQing, Chongqing, China
- Department of Emergency and Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University
-
-
Fujian
-
Fuzhou, Fujian, China
- The First Affiliated Hospital Of Fujian Medical University
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Department of CriticalCare Medicine, Guangdong General Hospital
-
-
Hainan
-
HaiKou, Hainan, China
- Department of Critical Care Medicine, Hainan Provincial People's Hospital
-
-
Hebei
-
Shijiazhuang, Hebei, China
- Department of Critical Care Medicine, Hebei Medical University Fourth Hospital
-
-
Heilongjiang
-
Harbin, Heilongjiang, China
- Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University
-
-
Henan
-
Zhengzhou, Henan, China
- ICU, The First Affiliated Hospital, Zhengzhou University
-
-
Hubei
-
WuHan, Hubei, China
- Department of Critical Care Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology
-
-
Hunan
-
Changsha, Hunan, China
- Department of Critical Care Medicine, Xiangya Hospital, Central South University
-
-
Inner Mongolia
-
Hohhot, Inner Mongolia, China
- Department of Critical Care Medicine, The Affiliated Hopsital of Inner Mongolia Medical University
-
-
Jilin
-
ChangChun, Jilin, China
- Department of Critical Care Medicine, The Second Hospital of Jilin University
-
-
Liaoning
-
Shenyang, Liaoning, China
- Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University
-
-
Ningxia
-
YinChuan, Ningxia, China
- General Hospital of Ningxia Medical University
-
-
Shandong
-
Jinan, Shandong, China
- Department of Critical Care Medicine, Qilu Hospital of Shandong University
-
-
Shanghai
-
Shanghai, Shanghai, China
- Emergency ICU, Ruijin Hospital, Shanghai Jiao Tong University
-
-
Shanxi
-
XiAn, Shanxi, China
- Surgical Intensive Care Unit, Xijing Hospital
-
-
Sichuan
-
Chengdu, Sichuan, China
- Department of Critical Care Medicine, West China Hospital, Sichuan University
-
-
Xinjiang
-
Urumqi, Xinjiang, China
- Department of Critical Care Medicine, First Affiliated Hospital, Xinjiang Medical University
-
-
Yunnan
-
Kunming, Yunnan, China
- Department of Emergency Medicine and Medical ICU, The First Affiliated Hospital of Kunming Medical University
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- Department of Critical Care Medicine, Zhejiang Provincial People's Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
all patients age >18 yrs admitted to 24 participating ICUs
Exclusion Criteria:
No patients should be excluded (regardless of age, underlying disease, life expectancy, etc).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
---|
ARDS, non-ARDS
patients with ARDS and patients without ARDS
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
incidence of acute respiratory distress syndrome (ARDS)
Tijdsspanne: from ICU admission to 28-day of ICU stay
|
incidence of ARDS = the number of patients developing ARDS during ICU / the total number of patients admitted to ICU
|
from ICU admission to 28-day of ICU stay
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
---|---|
ICU mortality of patients with ARDS
Tijdsspanne: followed up to 3 months after inclusion or to ICU discharge, whichever occurred first
|
followed up to 3 months after inclusion or to ICU discharge, whichever occurred first
|
hospital mortality of patients with ARDS
Tijdsspanne: followed up to 3 months after inclusion or to hospital discharge, whichever occurred first
|
followed up to 3 months after inclusion or to hospital discharge, whichever occurred first
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Bin Du, MICU of Peking Union Medical College Hospital
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MICU2015_1
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .